vendredi 12 février 2016

Onco Actu du 12 février 2016

1. Biologie

Good apart, better together [Broad Institute]

Using the laws of nature to predict tumour growth [The Institute of Cancer Research]

3.1 Tabac

The Importance Of Promoting Tobacco Cessation Services For Medicaid Beneficiaries [Health Affairs]

4.5 Dép., diag. & prono. - Colorectal

New test could help select the best treatment for bowel cancer patients [Cancer Research UK]

4.9 Dép., diag. & prono. - Sein

Testing for BRCA mutations reaches high levels among young women with breast cancer, study finds [Dana-Farber Cancer Institute]

5.2 Pharma

JAK inhibition for solid tumors flops, forcing Incyte to pull the plug on a slate of trials [FierceBiotech]

Incyte Falls on Jakafi Solid-Tumor Setback [TheStreet]

Incyte to stop pancreatic cancer drug trial [Reuters]

5.2.1 Pharma - Partenariats

AstraZeneca, Innate Pharma wrap up rollout of first wave of checkpoint inhibitor trials [FierceBiotech]

5.3 Traitements - FDA, EMA,...

FDA designated a record number of orphan drugs last year [STAT]

5.4 Traitements - Economie

Changing the Cancer Drugs Fund: a step towards fixing how the NHS provides the best medicines [Cancer Research UK]

6. Lutte contre les cancers

The death of cancer? Part 2: The War on Cancer and the politics of drug access [The Institute of Cancer Research]

Child cancer concerns 'ignored by GPs' [BBC News]

6.4 Médico-éco

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment [ReportLinker]

6.5 Médecines alternatives

Is it ethical to sell complementary and alternative medicine? [Science-Based Medicine]